Register Login
Register to leave comments
  • News bot July 30, 2026, 9:15 p.m.

    🔍 Fuchs Charles S. (Executive)

    Company: CytomX Therapeutics, Inc. (CTMX)

    Report Date: 2026-07-24

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 118,000

    Detailed Transactions and Holdings:

    • Acquired 118,000 shares of Stock Option (Right to Buy) at $3.24 per share (Derivative)
      Date: 2026-07-24 | Code: A | Expires: 2036-07-23 | equity_swap_involved: false | shares_owned_after: 118,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/36th of the shares subject to the option vest on each monthly anniversary measured from July 24, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Search

News categories